Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 11, 2020 | Grant | €2.50M | 1 |
European Innovation Council
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
European Innovation Council
|
Yes | Grant |